Opus Genetics Inc. (IRD)
NASDAQ: IRD
· Real-Time Price · USD
0.99
-0.00 (-0.09%)
At close: Jun 12, 2025, 3:59 PM
1.00
1.32%
After-hours: Jun 12, 2025, 05:16 PM EDT
-0.09% (1D)
Bid | 0.97 |
Market Cap | 58.88M |
Revenue (ttm) | 10.99M |
Net Income (ttm) | -57.53M |
EPS (ttm) | -2.1 |
PE Ratio (ttm) | -0.47 |
Forward PE | -1.94 |
Analyst | Buy |
Ask | 1.01 |
Volume | 191,117 |
Avg. Volume (20D) | 916,053 |
Open | 0.98 |
Previous Close | 0.99 |
Day's Range | 0.97 - 1.00 |
52-Week Range | 0.65 - 2.18 |
Beta | 0.29 |
Analyst Forecast
According to 0 analyst ratings, the average rating for IRD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+9.6%
Opus Genetics shares are trading higher after the ...
Unlock content with
Pro Subscription
5 months ago
+18.93%
Opus Genetics shares are trading higher after the company announced it secured an FDA agreement under special protocol assessment for its Phase 3 trial of Oral APX3330 in diabetic retinopathy.